COMPLETE KIT INCLUDEDbacteriostatic water, syringes, protocol and guide with every order

Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•

Research guide · Recovery & Repair

Relaxation PM 226 — research protocol

Relaxation PM 226 is a night-time recovery formula designed to promote deep relaxation, restorative sleep, and overnight recovery. Lyophilized powder in a 10ml presentation, 99% HPLC verified purity.

Evidence boundary

This guide summarizes study areas and sources associated with the compound. BioPeptideX does not convert experimental information into a clinical regimen or recommend an individual dose, frequency, route or duration.

Catalog presentations

10ml

Concentration table

Mathematical reference only; this is not a dosing recommendation.

This presentation is not expressed solely in milligrams; use the full calculator with the exact label values.

Research areas

  • Night-time relaxation and recovery formula
  • Supports deep, restorative sleep architecture
  • Buffers stress and calms the nervous system
  • Lyophilized powder for extended stability
  • 99% HPLC verified purity

Limited protocol information

We do not publish a cycle or dose range for this compound because the catalog references are not sufficient to support a responsible regimen. Consult the original publications and a licensed professional.

Handling and storage

Store unreconstituted product according to its label and maintain the cold chain where applicable. After any preparation, follow only validated instructions for the specific product and diluent. Do not use if packaging is damaged or the solution shows particles or unexpected changes.

Warnings

Do not use this page for self-diagnosis or self-medication. Pregnancy, breastfeeding, minors, cancer history, allergies, active disease and concurrent treatments require individual professional evaluation.

Published sources

  1. 1.García-Fernández M, et al. Sleep Sci, 2020.
  2. 2.Chen Y, et al. J Neurosci Res, 2019.